Cargando…
Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy in Children with Cancer: A Systematic Review and Meta-Analysis
SIMPLE SUMMARY: Vincristine is a drug that is part of the treatment for many children with cancer. Its main side-effect is vincristine-induced peripheral neuropathy (VIPN), which often presents as tingling, pain, and lack of strength in the hands and feet. It is not yet possible to predict which chi...
Autores principales: | Uittenboogaard, Aniek, Neutel, Céline L. G., Ket, Johannes C. F., Njuguna, Festus, Huitema, Alwin D. R., Kaspers, Gertjan J. L., van de Velde, Mirjam E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833506/ https://www.ncbi.nlm.nih.gov/pubmed/35158880 http://dx.doi.org/10.3390/cancers14030612 |
Ejemplares similares
-
Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam E., et al.
Publicado: (2022) -
Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes
por: Wright, Galen E.B., et al.
Publicado: (2018) -
Randomized controlled trial on the effect of 1‐hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)
por: Uittenboogaard, Aniek, et al.
Publicado: (2023) -
Population Pharmacokinetics of Vincristine Related to Infusion Duration and Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam Esther, et al.
Publicado: (2020) -
The association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer
por: van de Velde, Mirjam E., et al.
Publicado: (2021)